Development of an angiogenesis-focused cDNA chip and validation of its functionality

Experimental and Molecular Medicine

Volumn 37, Issue 4, 2005, Pages 365-370

  Shim, Joong Sup ^a   Lee, Hae Kwang ^b   Park, Hyo Mi ^a   Kim, Jong Ok ^b   Kim, Eun Kyung ^b   Hwang, Kyung Hoon ^b   Kim, Ki Tae ^b   Park, Seong Whan ^b   Lee, Je Hyeon ^b   Kwon, Ho Jeong ^a  

^a Sejong University   (South Korea)

^b Biotechnology Community Bio 21   (South Korea)

Author keywords

Angiogenesis; DNA chip; Duplicate spots, gene expression profile; Histone deacetylase

Indexed keywords

COMPLEMENTARY DNA; TRICHOSTATIN A; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR;

ANGIOGENESIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; SERUM; VALIDATION PROCESS; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION; INSTRUMENTATION; NEOVASCULARIZATION (PATHOLOGY); VALIDATION STUDY;

BOVINAE;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR CELLS, CULTURED;

EID: 24944477704     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2005.46     Document Type: Article

References (28)

1. Butte A. The use and analysis of microarray data. Nat Rev Drug Discov 2002;1:951-60
2. Cinatl J Jr, Kotchetkov R, Blaheta R, Driever PH, Vogel JU, Cinatl J. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha. Int J Oncol 2002;20:97-106
3. Colville-Nash PR, Scott DL. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 1992;51:919-25
4. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-8
5. Deroanne CF, Bonjean K, Servotte S, Devy L, Colige A, Clausse N, Blacher S, Verdin E, Foidart JM, Nusgens BV, Castronovo V. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 2002;21:427-36
6. Folkman J. Angiogenesis in psoriasis: therapeutic implications. J Invest Dermatol 1972;59:40-3
7. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6
8. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997;389:349-52
9. Haas TL, Madri JA. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis. Trends Cardiovasc Med 1999;9:70-7
10. Hassig CA, Tong JK, Schreiber SL. Fiber-derived butyrate and the prevention of colon cancer. Chem Biol 1997;4:783-9
11. Hoshikawa Y, Kwon HJ, Yoshida M, Horinouchi S, Beppu T. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res 1994;214:189-97
12. Kim JH, Shim JS, Lee SK, Kim KW, Rha SY, Chung HC, Kwon HJ. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Jpn J Cancer Res 2002;93:1378-85
13. Kim JR, Lee SR, Chung HJ, Kim S, Baek SH, Kim JH, Kim YS. Identification of amyloid beta-peptide responsive genes by cDNAmicroarray technology: Involvement of RTP801 in amyloid beta-peptide toxicity. Exp Mol Med 2003;35:403-11
14. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY, Kim CW, Kim KW. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001;7:437-43
15. Kim YH, Lee JH, Lim DS, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK. Gene expression profiling of oxidative stress on atrialfibrillation in humans. Exp Mol Med 2003;35:336-49
16. Kothapalli R, Yoder SJ, Mane S, Loughran TP Jr. Microarray results: how accurate are they? BMC Bioinformatics 2002; 3:22
17. Kwon HJ, Kim MS, Kim MJ, Nakajima H, Kim KW. Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int J Cancer 2002;97:290-6
18. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, Stoughton R, Burchard J, Slade D, Dai H, Bassett DE Jr, Hartwell LH, Brown PO, Friend SH. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 1998;4:1293-301
19. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-5
20. Mori A, Arii S, Furutani M, Hanaki K, Takeda Y, Moriga T, Kondo Y, Gorrin Rivas MJ, Imamura M. Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model. Int J Cancer 1999;80:738-43
21. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 1992;285(Pt2):603-11
22. Moses MA, Langer R. A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem 1991;47:230-5
23. Rand LI. Recent advances in diabetic retinopathy. Am J Med 1981;70:595-602
24. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70
25. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987;325:257-9
26. Shalon D, Smith SJ, Brown PO. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res 1996;6:639-45
27. Shim JS, Kim DH, Kwon HJ. Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. Oncogene 2004;23:1704-11
28. Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 1990;111:765-72